Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Catriona Yale currently holds 74,800 shares of Akero Therapeutics, Inc. (AKRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Catriona Yale has been a net seller of AKRO stock. They have purchased $0 and sold $7.4M worth of shares.
Catriona Yale's most recent insider trade was on Dec 9, 2025, when they sold 47,573 shares at $0.00 per share.
Catriona Yale serves as Executive at Akero Therapeutics, Inc. (AKRO). They have executed 85 insider transactions totaling $7.4M over their tenure at the company.
Catriona Yale holds the position of Executive at Akero Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Catriona Yale has shown a selling trading pattern, with $0 in total purchases and $7.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Catriona Yale was on Mar 4, 2024, when they sold $732.7K worth of AKRO shares. This transaction involved 20,646 shares at $35.49 per share.
Catriona Yale currently owns 74,800 shares of Akero Therapeutics, Inc. (AKRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Catriona Yale's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Catriona Yale has 85 Form 4 filings on record as an insider at Akero Therapeutics, Inc..
Set alerts for Catriona Yale and 40,000+ other insiders.